Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Clinical trial NCT03897036 · COMPLETED
Trial details
- NCT number
- NCT03897036
- Sponsor
- Senhwa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2024-01-25
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.